NCT00009841View on ClinicalTrials.gov

Gene Therapy in Treating Patients With Advanced Head and Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL

EGFR antisense DNA

BIOLOGICAL

growth factor antagonist therapy

DRUG

DC-cholesterol liposome

Trial Locations (1)

15213-3489

University of Pittsburgh Cancer Institute, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pittsburgh

OTHER

NCT00009841 - Gene Therapy in Treating Patients With Advanced Head and Neck Cancer | Biotech Hunter | Biotech Hunter